Post Marketing Study to Evaluate the Two Dose Regimens of Nicardipine Injection in Hypertensive Emergency Patients

NCT01872039 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

163

Enrollment

INDUSTRY

Sponsor class

Conditions

Hypertension Emergency
End-organ Damage

Interventions

DRUG: Perdipine injection

Sponsor

Astellas Pharma China, Inc.